October 15, 2021 – Journey Biosciences, Inc. announced a collaboration with Cardinal Health (Dublin, OH) OptiFreight Logistics that will increase control and visibility across every transportation modality. Journey Biosciences is a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD).
The collaboration will deliver Journey Biosciences’ first-of-its-kind NaviDKD medical diagnostics screening technology to the point-of-care where innovative testing and risk evaluation takes place using cutting-edge proprietary algorithms, which will enable healthcare providers to more proactively diagnose and manage long-term complications associated with diabetes.
Journey Biosciences’ mission is to fundamentally improve diabetes care by providing health care professionals and people with diabetes the necessary diagnostic screening tools to proactively manage and prevent high risk complications associated with DKD.
OptiFreight Logistics delivers complete logistics management for the healthcare industry. As Journey Biosciences expands across the industry, OptiFreight Logistics will provide customized logistics solutions with increased visibility for critical healthcare deliveries to enhance the diagnostic screening process.
Terms of the agreement were not disclosed.